Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing v3.4.2. This appears to be a minor version update without changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:16.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Removal of metadata topics 'Head and neck squamous cell carcinoma' and related terms like 'MedlinePlus Genetics' from the page may affect indexing and search filters, but does not change the trial content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T16:26:35.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Adds contextual tags such as 'Head and neck squamous cell carcinoma' and related topic links (MedlinePlus Genetics) and updates revision notes; removes a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T11:30:06.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T07:00:48.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    These are minor UI and metadata updates, including a new 'Show glossary' option, a new 'Last Update Submitted that Met QC Criteria' label, the addition of 'No FEAR Act Data', and the new 'Revision: v3.4.0' tag (with corresponding removals of 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:04.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:11:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.